APA (7th ed.) Citation

E, R., F, P., C, B., A, M., F, P., S, D. M., . . . M, B. (2022). The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma. Biomedicines, 10(3), . https://doi.org/10.3390/biomedicines10030659

Chicago Style (17th ed.) Citation

E, Rango, et al. "The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma." Biomedicines 10, no. 3 (2022). https://doi.org/10.3390/biomedicines10030659.

MLA (9th ed.) Citation

E, Rango, et al. "The Pyrazolo[3,4-d]Pyrimidine Derivative Si306 Encapsulated into Anti-GD2-Immunoliposomes as Therapeutic Treatment of Neuroblastoma." Biomedicines, vol. 10, no. 3, 2022, https://doi.org/10.3390/biomedicines10030659.